NEAR MISS: CLINICAL CASES OF PREGNANCY OUTCOMES IN WOMEN WITH COVID-19

• Main Authors: Нонна Марковна Шибельгут (Author), Наталья Анатольевна Батина (Author), Вадим Гельевич Мозес (Author), Елена Владимировна Рудаева (Author), Светлана Ивановна Елгина (Author), Сергей Валерьевич Рыбников (Author), Кира Борисовна Мозес (Author), Ольга Борисовна Карелина (Author), Елена Владимировна Золото (Author)
• Format: Book
• Published: The Publishing House Medicine and Enlightenment, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

COVID-19 leads to cytokine storm, systemic inflammatory response and coagulopathy, which is one of the worst prognostic factors. Coagulopathy in COVID-19 is accompanied by a pronounced increase in the level of D-dimer and degradation products of fibrin / fibrinogen, while deviations of other indicators (prothrombin time, activated partial thromboplastin time, platelet count) are relatively rare at the onset of the disease. All pregnant women are offered a screening test for coagulation, including the determination of the level of D-dimer and fibrinogen. For coagulopathy associated with COVID-19, empiric anticoagulant therapy is required to prevent venous thrombosis and thromboembolism, as well as standard maintenance therapy for sepsis-induced coagulopathy or disseminated intravascular coagulation syndrome.

Item Description

1991-010X
2542-0968